Home > Insider Trading > Emergent Biosolutions Inc. > Profile

Emergent Biosolutions Inc. (EBS)

Market is closed

Sector: Pharmaceutical Preparations

Insider Roster

Jessica Perl, Svp, General Counsel, Corp Sec, 2026-02-11
Coleen Glessner, Evp, Quality & Ethics, and Cpl, 2026-02-11
Anthony Paul Williams, Svp, Products Business, 2026-02-11

Jessica Perl, Svp, General Counsel, Corp Sec, 2026-02-11
Coleen Glessner, Evp, Quality & Ethics, and Cpl, 2026-02-11
Anthony Paul Williams, Svp, Products Business, 2026-02-11
William Hartzel, Svp, Bioservices, 2026-02-11
S Richard Lindahl, Evp, Chief Financial Officer, 2026-02-11
C Simon Lowry, Svp, R&D, Cmo, 2025-12-16
Ronald Richard, Director, 2025-12-09
W Donald Degolyer, Director, 2025-11-12
Tyagi Sujata Dayal, Director, 2025-11-10
C Kathryn Zoon, Director, 2025-08-18
Keith Katkin, Director, 2025-05-28
C Joseph Papa, President and Ceo, 2025-05-15
L Marvin White, Director, 2025-05-03
Franklin Neal Fowler, Director, 2025-05-03
Zsolt Harsanyi, Chairman, 2025-05-03
W Louis Sullivan, Director, 2025-05-03
Lynne Jennifer Fox, Evp, Ext Aff, Gc, Corp Sec, 2024-07-12
Iii Haywood H Miller, Interim Ceo, 2023-07-18
Adam Havey, Evp, Business Operations, 2023-06-14
Robert Kramer, President and Ceo, 2023-06-14
M Jerome Hauer, Director, 2023-05-30
Atul Saran, Evp, Chief Strat & Dev Officer, 2023-03-02
Katherine Strei, Evp, Chief Hr Officer, 2023-03-02
A George Joulwan, Director, 2022-05-31
Fuad El-Hibri, Director, 2021-12-08
L. Karen Smith, Evp, Chief Medical Officer, 2021-05-11
Sean Kirk, Evp, Manufacturing & Tech Ops, 2021-04-01
Sue Bailey, Director, 2021-03-08
Emergent Biosolutions Inc., Other, 2019-06-04
Seamus Mulligan, Director, 2019-03-21
Daniel Abdun-Nabi, Ceo, 2019-03-04
John Niederhuber, Director, 2016-05-23
Barry Labinger, Evp, Biosciences Div., 2015-11-17
Steven Chatfield, Evp, Biosciences, 2013-03-18
Intervac, L.l.c., Large Shareholder, 2012-09-21
Don R Elsey, Chief Financial Officer, 2012-03-16
Kyle Keese, Evp, Biosciences Division, 2011-03-17
Stephen Lockhart, Svp Product Development, 2010-11-16
Biopharm, L.l.c., Large Shareholder, 2010-06-01

Show All Insiders (39)

Hedge Fund Popularity

Display

Display Share Price

Display Large Version

Hedge Fund Holdings

Filing Period:

Last updated on February 17, 2026, 4:43pm based on SEC 13F filings Last update: February 17, 2026, 4:43pm

No.	Hedge Fund	Shares	Value	Activity	% Port
1.	Jain Global LLC Bobby Jain	942,691	$11,651,661	+86%	0.06%
2.	Prescott Group Capital Management Phil Frohlich	772,771	$9,551,450		0.89%
3.	Marshall Wace LLP Paul Marshall And Ian Wace	743,455	$9,189,104	-19%	0.01%
4.	D E Shaw D. E. Shaw	723,217	$8,938,962	+126%	0%
5.	Renaissance Technologies Jim Simons	577,147	$7,133,537	+12%	0.01%

Insider Trading: Purchases See All

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Papa Officer, Director	$5.83	60,000	$349,800.00	342,500	2025-05-13	Filing
Lindahl Officer	$37.46	3,000	$112,380.00	39,919	2021-11-15	Filing
Havey Officer	$27.08	98	$2,653.84	41,444	2015-06-01	Filing
Abdun-Nabi Officer, Director	$19.08	749	$14,290.92	103,373	2013-11-30	Filing
Abdun-Nabi Officer, Director	$12.07	800	$9,656.00	96,011	2013-05-31	Filing

Insider Trading: Sales See All

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Richard Director	$11.90	14,884	$177,086.86	98,417	2025-12-05	Filing
Richard Director	$12.11	7,100	$85,990.23	98,417	2025-12-05	Filing
Degolyer Director	$10.54	17,801	$187,622.54	119,858	2025-11-10	Filing
Dayal Director	$10.00	8,552	$85,520.00	88,980	2025-11-07	Filing
Glessner Officer	$10.00	30,608	$306,080.00	144,319	2025-10-07	Filing

Institutional Investors' Holdings

Filing Period:

No.	Name	Shares	Value	% Port
1.	Blackrock, Inc.	4,254,397	$52,584,347	0%
2.	Vanguard Group Inc	3,553,999	$43,927,428	0%
3.	State Street Corp	2,696,375	$33,327,195	0%
4.	American Century Companies Inc	2,439,439	$30,151,466	0.02%
5.	Dimensional Fund Advisors Lp	2,252,605	$27,840,949	0.01%

News See All

Click here to See All News